Allakos Inc. (ALLK)
NASDAQ: ALLK · Real-Time Price · USD
1.190
+0.140 (13.33%)
At close: Oct 24, 2024, 4:00 PM
1.120
-0.070 (-5.88%)
After-hours: Oct 24, 2024, 5:22 PM EDT
Allakos Market Cap
Allakos has a market cap or net worth of $105.73 million as of October 24, 2024. Its market cap has decreased by -46.76% in one year.
Market Cap
105.73M
Enterprise Value
9.91M
1-Year Change
-46.76%
Ranking
Category
Stock Price
$1.19
Market Cap Chart
Since July 19, 2018, Allakos's market cap has decreased from $1.24B to $105.73M, a decrease of -91.48%. That is a compound annual growth rate of -32.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2024 | 93.30M | -60.93% |
| Dec 29, 2023 | 238.80M | -66.71% |
| Dec 30, 2022 | 717.40M | 34.93% |
| Dec 31, 2021 | 531.70M | -92.77% |
| Dec 31, 2020 | 7.35B | 58.39% |
| Dec 31, 2019 | 4.64B | 110.83% |
| Dec 31, 2018 | 2.20B | 77.37% |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Relmada Therapeutics | 107.57M |
| Assembly Biosciences | 107.18M |
| So-Young International | 106.09M |
| Sensus Healthcare | 105.46M |
| Elutia | 105.25M |
| I-Mab | 103.83M |
| CervoMed | 103.09M |
| Karyopharm Therapeutics | 103.00M |